Atossa Therapeutics (ATOS) Earnings Date & Reports

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovative medicines in areas of unmet medical need in oncology... Show more

Industry: #Medical Specialties

Get AI intraday signals

A.I. Advisor

published Earnings

ATOS is expected to report earnings to rise 62.50% to -6 cents per share on May 19

Atossa Therapeutics ATOS Stock Earnings Reports

Q1'25

Est.

$-0.06

Q4'24

Beat

by $0.02

Q3'24

Est.

$-0.06

Q2'24

Beat

by $0.01

Q1'24

Beat

by $0.02

The last earnings report on March 25 showed earnings per share of -3 cents, beating the estimate of -6 cents. With 505.24K shares outstanding, the current market capitalization sits at 87.11M.

View a ticker or compare two or three

Compare

ATOS